Wellington Management Group LLP Boosts Stock Position in Amdocs Limited (NASDAQ:DOX)

Wellington Management Group LLP lifted its position in shares of Amdocs Limited (NASDAQ:DOX) by 2.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,318,519 shares of the technology company’s stock after purchasing an additional 29,202 shares during the period. Wellington Management Group LLP owned 1.12% of Amdocs worth $115,885,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the company. Financiere des Professionnels Fonds d investissement inc. lifted its holdings in shares of Amdocs by 1.3% during the fourth quarter. Financiere des Professionnels Fonds d investissement inc. now owns 9,790 shares of the technology company’s stock valued at $860,000 after purchasing an additional 130 shares during the last quarter. Wahed Invest LLC increased its position in shares of Amdocs by 9.8% during the third quarter. Wahed Invest LLC now owns 1,870 shares of the technology company’s stock valued at $158,000 after acquiring an additional 167 shares in the last quarter. True Wealth Design LLC increased its position in shares of Amdocs by 2.0% during the fourth quarter. True Wealth Design LLC now owns 8,626 shares of the technology company’s stock valued at $758,000 after acquiring an additional 170 shares in the last quarter. Operose Advisors LLC increased its position in shares of Amdocs by 148.0% during the third quarter. Operose Advisors LLC now owns 310 shares of the technology company’s stock valued at $26,000 after acquiring an additional 185 shares in the last quarter. Finally, Blue Trust Inc. increased its position in shares of Amdocs by 17.9% during the fourth quarter. Blue Trust Inc. now owns 1,418 shares of the technology company’s stock valued at $119,000 after acquiring an additional 215 shares in the last quarter. 92.02% of the stock is currently owned by hedge funds and other institutional investors.

Amdocs Trading Up 2.1 %

Shares of DOX stock opened at $77.99 on Friday. Amdocs Limited has a 1 year low of $74.41 and a 1 year high of $99.75. The firm has a fifty day moving average price of $81.36 and a 200-day moving average price of $86.93. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market cap of $9.17 billion, a price-to-earnings ratio of 17.53, a PEG ratio of 1.35 and a beta of 0.74.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Wednesday, May 8th. The technology company reported $1.38 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.05). Amdocs had a net margin of 10.62% and a return on equity of 17.85%. The business had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.25 billion. As a group, equities analysts predict that Amdocs Limited will post 5.72 earnings per share for the current year.

Amdocs Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.46%. The ex-dividend date is Friday, June 28th. Amdocs’s dividend payout ratio (DPR) is 43.15%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on DOX shares. Citigroup reduced their price target on shares of Amdocs from $105.00 to $100.00 and set a “buy” rating for the company in a research report on Thursday, May 9th. Robert W. Baird reduced their price target on shares of Amdocs from $97.00 to $90.00 and set a “neutral” rating for the company in a research report on Thursday, May 9th. Finally, StockNews.com downgraded shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday, March 15th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $103.80.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.